Rob Lavine, News editor for Global Corporate Venturing, reviews the trends in venturing from 2018

Indian Institute of Management, Ahmedabad joined Unitus Ventures and Axilor Ventures to supply seed capital to radiology directory 5C Network, which helps hospitals access radiology expertise.

Alphabet's healthcare spinoff, Verily, is doubling the amount of companies in its investment and collaboration hub to about 15 participants.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

GE Ventures is reportedly being considered for a spinoff as part of an ongoing, wide-ranging reorganisation of General Electric.

Based on Lund University research, group B streptococcus vaccine developer Minervax has now raised $11.4m from investors including Novo.

AIG made its second investment in genetic disease drug developer BridgeBio Pharma having also backed a $135m round less than 18 months ago.

The birth control and contraceptive delivery service has increased its funding to $67m altogether in a series B round backed by Alphabet subsidiary GV.

The Legend Capital-backed cancer technology developer has closed a $20.4 round featuring Shougang to increase its total funding to more than $27m.

Novo Holdings has invested more than $22m of its $165m fund across four companies developing drugs meant to combat antimicrobial resistance.